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Abstract To explore the effects of LYRM1 knockdown on
proliferation, apoptosis, differentiation and mitochondrial
function in the embryonic carcinoma (P19) cell model of car-
diac differentiation. Knockdown of LYRM1 using small inter-
fering RNA (siRNA) was confirmed by quantitative real-time
PCR. Cell Counting Kit-8(CCK-8) proliferation assays and
cell cycle analysis demonstrated that LYRM1 gene silencing
significantly inhibited P19 cell proliferation. Flow cytometry
and measurement of their caspase-3 activities revealed that
knockdown of LYRM1 increased P19 cell apoptosis.
Observation of morphological changes using an inverted mi-
croscope and expression analysis of specific differentiation
marker genes using quantitative real-time PCR and Western
blotting revealed that knockdown of LYRM1 significantly
inhibited the differentiation of P19 cells into cardiomyocytes.
Furthermore, real-time quantitative PCR applied to detect mi-
tochondrial DNA (mtDNA) copy number implied that there
was no significant difference in the LYRM1 knockdown
group compared with the control group. Cellular ATP produc-
tion investigated by luciferase-based luminescence assay was
dramatically decreased in differentiated cells transfected
with LYRM1 RNAi. Fluorescence microscopy and flow
cytometery were used to detect the reactive oxygen species
(ROS) and the mitochondrial membrane potential (MMP)
showed that the level of ROS was dramatically increased
and MMP was obviously decreased in differentiated cells
transfected with LYRM1 RNAi. Collectively, knockdown
of LYRM1 promoted apoptosis and suppressed prolifera-
tion and differentiation in P19 cells. In addition, knock-
down of LYRM1 induced mitochondrial impairment in
P19 cells during differentiation, which was reflected by
decreased ATP synthesis, lower MMP and increased ROS
levels.
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Introduction
Heart development is an extremely complex process, which
involves precisely temporal and spatial expression of many
genes associated with embryonic development (Christoffels
et al. 2000). Research shows cardiac structure and function
are quite sensitive to genetic perturbation during cardiogenesis
in human and that mutations in components of the cardiac
gene network can lead to adverse consequences in the form
of congenital heart disease (CHD) (Olson 2006). At present,
congenital heart disease, broadly grouped into two major cat-
egories: morphological and functional abnormalities of the
heart and great vessels, is the most common kind of congenital
abnormalities found at birth and the significant cause of neo-
natal morbidity and mortality, which brings a heavy burden on
families and society (Hoffman et al. 2004). Thus, exploring
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molecular etiology is still the key to the prevention and treat-
ment of CHDs.
In our earlier studies, we found and cloned Homo sapiens
LYR motif containing 1 (LYRM1), a novel gene that showed
the highest expression level in adipose tissue and also abun-
dantly expressed in human heart tissue (Qiu et al. 2009). We
found that LYRM1 had an effect on differentiation, prolifera-
tion and apoptosis in 3 T3-L1 pre-adipocytes and also influ-
enced mitochondrial function in mature 3 T3-L1 adipocytes
(Cao et al. 2010; Qiu et al. 2009; Zhu et al. 2012). In addition,
Studies have shown that LYRM1 was a member of the
Complex1_LYR superfamily, and LYR proteins were pre-
dominantly mitochondrial proteins and influenced mitochon-
drial homeostasis (Angerer 2013; Pagliarini et al. 2008).
These findings indicate that LYRM1 plays a significant role
in cell growth, apoptosis and mitochondrial function. Further
studies by our group revealed that overexpression of LYRM1
promoted proliferation and inhibited apoptosis in embryonic
myocardial cells, which Indicated that the LYRM1 gene may
play a vital role in the development of the human heart (Zhu
et al. 2010). However, the specific mechanism of LYRM1 in
heart development remains unclear.
P19 cells, isolated from an experimental embryo-derived
mouse teratocarcinoma, are used widely as a suitable myocar-
dial cell model to investigate cardiac differentiation at the
molecular and functional levels (van der Heyden et al. 2003;
Wen et al. 2007). Accordingly, we chose this model to inves-
tigate the effect of LYRM1 knockdown on cell proliferation,
apoptosis, differentiation and mitochondrial function.
Materials and methods
Cell culture and differentiation
P19 cells were purchased from the American Type
Culture Collection (ATCC, Manassas, VA, USA). P19
cells were cultured in complete medium composed by
α-MEM culture medium (Gibco, NY, USA) with 10 %
fetal bovine serum (FBS, Gibco BRL), 100μg/ml peni-
cillin, and 100 μg/ml streptomycin at 37 °C in 5 %
CO2. To induce cardiac differentiation, P19 cells were
maintained in complete medium supplemented with 1 %
dimethyl sulfoxide (DMSO, Sigma, St. Louis, MO,
USA) and aggregated over the following 4 days to form
embryoid bodies (EBs) , and the medium was
replenished every 24 h. The formed EBs were trans-
ferred to 6-well culture plates and cultured in complete
medium free of DMSO for an additional 4 or 6 days.
The morphologic changes in P19 cells were observed
and photographed using an inverted microscope
(Nikon, Japan). Cell total RNAs and proteins were ex-
tracted on day 0, 6 and 10 during differentiation.
Construction of RNAi lentiviral vector and establishment
of LYRM1 silenced cells
RNAi lentiviral vector was constructed as previously de-
scribed (Zhu et al. 2012). Briefly, the designed short hairpin
RNA (shRNA) construct contained a 19-nt double-stranded
LYRM1 sequence, which was an inverted complementary re-
peat that formed a loop sequence (5′-CTCGAG- 3′). The 5′
overhangs, CCGG and AATT, were ligated into AgeI- and
EcoRI-digested pgLV-U6-puro lentivirus vector in the
positive-sense and antisense strands, respectively. The recom-
binant vector was named pgLV-U6-puro-LYRM1-shRNA.
The negative control vector (pgLV-U6-puro-NC-shRNA)
contained a nonsense shRNA insert to control any effects
caused by non-RNAi mechanisms. The sequences of the
cDNA fragment (positive-sense strand) were as follows:
LYRM1, 5′GCAATCATTTCTAGACTAA; negative control,
5′TTCTCCGAACGTGTCACGT.
We co-transfected the HEK-293 T cells with three opti-
mized packaging plasmids (pGag/Pol, pRev and pVSV–G)
and the pgLV-U6-puro-LYRM1-shRNA or pgLV-U6-puro-
NC-shRNA expression clone construct, which could produce
lentiviral stocks with a suitable titer. The collected lentiviral
supernatant filtered through a 0.45 um membrane were sup-
plemented with hexadimethrine bromide (polybrene) to a final
concentration of 5μg/ml and applied directly to P19 cells.
Stably transduced P19 cells were selected in medium contain-
ing 2 μg/ml puromycin (Sigma-Aldrich, St. Louis, MO, USA)
over 2 weeks. The efficiency of knockdown was detected by
real-time quantitative polymerase chain reaction (qPCR)
using the primers shown in Table 1.
Cell growth assay
Cell proliferation rate was evaluated using the WST-8 Cell
Counting Kit-8 (Dojindo, Tokyo, Japan) according to the
manufacturer’s instructions. Briefly, seeded in 96-well plate,
the cells were incubated in a-MEM supplemented with 10 %
FBS for 4 days. CCK-8 reagent (10 μl, 1 mg/ml) was added
and incubated for 3 h at 37 °C. Then, we used a microplate
reader (Bio-Rad, Hercules, CA, USA) to measure the absor-
bance at 450 nm.
Cell cycle assay
In order to synchronize the cell cycle, we cultivated the cells in
serum-free α-MEM for 24 h before analysis. After serum
deprivation, Cells were incubated with complete medium for
0 and 24 h. Following incubation, cells were harvested using
trypsin/EDTA, fixed in 70 % ethanol at 4 °C overnight, and
cellular DNAwas stained with 500 μL propidium iodide (PI)
(BD Bioscience, San Diego, CA, USA). The DNA content of
104 cells was analyzed by a FACSCalibur flow cytometer
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(BD Bioscience) and the population in each cell cycle phase
was analyzed using FlowJo software (FlowJo, Ashland, OR,
USA).
Apoptosis assay
Apoptotic cells were assayed by flow cytometric analysis of
annexin V–allophycocyanine (APC) and 7-amino-
actinomycin D (7-AAD) staining. The cells were cultivated
in serum-free α-MEM for 24 h to induce apoptosis, collected
by trypsin without EDTA (Gibco BRL, USA) and washed
with phosphate-buffered saline (PBS, Gibco BRL). After cen-
trifuged and resuspended, the cells were stained with 5 μL
Annexin V-APC and 5 μL 7-AAD at room temperature for
15 min (Biovision, CA, USA). Flow cytometry was then used
to analyze the cells immediately.
Assay of caspase-3 activity
We used a CaspGLOW Fluorescein Active Caspase-3
Staining Kit (Biovision, CA, USA) to analyze the caspase-3
activity of cells. Cells (1 × 106/ml) were induced apoptosis by
method of serum deprivation and we concurrently incubated a
control culture without induction. An additional negative con-
trol can be prepared by adding the caspase inhibitor Z-VAD-
FMK at 1 μl/ml to an induced culture to inhibit caspase-3
activation. We put aliquot 300 μl each of the induced and
control cultures into eppendorf tubes and added 1 μl of
FITC-DEVD-FMK into each tube and incubated for 0.5–1 h
at 37 °C incubator with 5 % CO2. Then, we centrifuged cells
at 3000 rpm for 5 min and resuspended cells in 0.5 ml ofWash
Buffer, and centrifuged again, resuspended cells in 300 μl of
Wash buffer. The samples were analyzed by flow cytometry
using the FL-1 channel (BD Bioscience).
Quantitative real-time PCR
Total RNAs from P19 cells transfected with lentiviral-
LYRM1-shRNA or lentiviral-NC-shRNA were extracted
using TRIzol reagent (Invitrogen). Reverse transcription was
performed using a RevertAid First Strand cDNA Synthesis
Kit (Thermo Scientific, Pittsburgh, PA, USA). Real-time
PCR (SYBR Green method) was performed using 7500 Fast
System Real-Time PCR cycler (Applied Biosystems) accord-
ing to the manufacturer’s protocols. The relative gene expres-
sion levels were quantified based on the Ct and normalized
against a reference gene, GAPDH. The sequences of the
primers are shown in Table 1.
Real-time PCR was used to determine the relative amounts
of mitochondrial DNA (mtDNA), as described previously
(Kaaman et al. 2007). We exacted DNA from differentiated
cells using a DNA Exaction Kit (QIAGEN, Dusseldorf,
Germany). Two primer sets were used for PCR analysis. A
110-nt mtDNA fragment within the cytochrome B gene
(CYTB) was used for the quantification of mtDNA.
Previously, the PCR product had been inserted into the plas-
mid pMD-T18 and verified by DNA sequencing. According
to the plasmid standards of known copy number,we got a log-
linear standard curve, through which the CYTB copy numbers
of the samples could be detected by real-time PCR conducted
on the ABI 7500 Sequence Detection System. The 291-bp
region of the nuclear gene for 28 S was used as normalization
standard. The ratio of mtDNA to nuclear DNAwas counted to
reflect the copy number of mitochondrial per cell.
Antibodies and Western blotting
Anti-GAPDH antibodies purchased from Proteintech Group
(Proteintech, USA), anti-GATA4 and anti-Nkx 2.5 antibodies
were both from Abcam (Abcam plc, Cambridge, UK). Total
proteins from cultured cells were extracted using the Total
Protein Extraction Kit (KeyGen, inc., China). Subsequently,
the protein concentrations were measured by a bicinchoninic
acid (BCA) assay kit (KeyGen, Nanjing, China).We separated
the proteins by 10 % SDS–polyacrylamide gel electrophore-
sis, and then transferred onto polyvinylidene difluoride mem-
branes. After blocked by the 5 % dried skimmed milk at room
temperature for 2 h, the membranes were incubated with the
corresponding primary antibodies overnight at 4 °C. We
washed the membranes three times with Tris-buffered saline
with Tween 20 (TBST), and used appropriate horseradish per-
oxidase–conjugated secondary antibody to incubate them at
Table 1 PCR primer sequences used
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room temperature for 2 h. Proteins were detected using ECL
plus reagents (Beyotime, Shanghai, China).
Measurement of cellular ATP production
Using a Luciferase-Based Luminescence Assay Kit (Biyutian,
Nantong, China), we measured the cellular adenosine triphos-
phate (ATP) on the 10th day of differentiation. Briefly, the
differentiated P19 cells were homogenized in an ice-cold
ATP-releasing buffer, and then we determined the ATP con-
centrations with a single-tube luminometer (Turner
Biosystems, USA). The production of ATP was normalized
to protein concentration determined by the BCA method.
Fluorescence microscopy and flow cytometry
We measured the intracellular ROS levels by a 2′, 7′-
dichlorodihydrofluorescein diacetate acetyl ester (H2-
DCFDA) probe (Sigma, St. Louis, MO, USA) (Maxwell
et al. 1999), and evaluated the mitochondria membrane poten-
tial (MMP) by a JC-1 fluorescent probe from the
Mitochondrial Membrane Potential Detection Kit (Biyutian,
China). The cells were incubated with 1 ml of JC-1 or 5 μMof
DCFDA for 30 min at 37 °C, washed three times with pre-
warmed PBS, and then imaged under a fluorescence micros-
copy. For flow cytometry, following trypsinization and centri-
fugation, the stained cells were resuspended in 300 μl PBS
buffer. The fluorescence were analyzed with a FACScan flow
cytometer with the CellQuest software (BD Biosciences, San
Joes,CA, USA).
Statistical analysis
Each experiment was performed at least three times. All data
were expressed as means ±standard error of the mean (SED).
Statistical analysis was performed using Student’s t-test with
the SPSS 16.0 statistical software package (SPSS Inc.,
Chicago, IL, USA). The threshold of statistical significance
was defined as P < 0.05.
Results
Appraisal of LYRM1 suppression efficiency
The knockdown efficiency of LYRM1 was evaluated by real-
time PCR. The relative LYRM1mRNA level in P19 cells was
normalized against the mRNA levels of a reference gene,
GAPDH. As shown in Fig. 1, cells infected with pGLV–
LYRM1–shRNA expressed significantly lower levels of
LYRM1 mRNA than the cells transfected with the negative
control (NC) lentiviral construct (*P < 0.05). The steady state
LYRM1mRNA level of the pGLV–LYRM1–shRNA-infected
cells was 51 % that of the negative control cells before differ-
entiation. On the 10th day of differentiation, the LYRM1
mRNA level of the pGLV–LYRM1–shRNA-infected cells
was 58 % that of the negative control cells.
LYRM1 gene silencing reduces P19 cell proliferation
We used the CCK-8 assay to assess the growth of LYRM1-
silenced and NC P19 cells for 96 h. As shown in Fig. 2a,
LYRM1-silenced cells significantly reduced growth rate com-
pared to NC control cells. From 48 h onwards, the OD values
of LYRM1-silenced cells were significantly lower than con-
trol cells (**P < 0.01). Further, we performed flow cytometry
analysis of the cell cycle distribution in LYRM1-silenced and
NC control P19 cells, and observed that the proportion of S
phase cells in LYRM1-silenced P19 cells was much lower
than NC control cells and G1 phase fraction in LYRM1-
silenced P19 cells was distinctly increased (Fig. 2b).
LYRM1 gene silencing induces P19 cell apoptosis
To test the effect of LYRM1 knockdown on cell apoptosis, we
induced apoptosis of P19 cells by serum starvation for 24 h,
and then the cells were cultured in complete media for 24 h.
After staining with Annexin V-APC/7-AAD probe, the num-
bers of apoptotic cells were quantified by flow cytometric
analysis. The data indicated that LYRM1 knockdown in-
creased the number of apoptotic cells in response to serum
deprivation (*P < 0.05; Fig. 3a,b). In addition, the caspase-3
activity assay also demonstrated that LYRM1 knockdown in-
creased the number of apoptotic cells in response to serum
deprivation(*P < 0.05,Fig. 3c,d). These results indicated that
LYRM1 gene silencing promotes serum deprivation-induced
apoptosis.
Differentiation of P19 cells cardiomyocytes
P19 cells were differentiated into the cardiomyocytes by 1%
DMSO. The morphological changes during differentiation
were observed by an inverted microscope. As shown in
Fig. 4a, P19 cells aggregated into embryoid bodies (EBs) in
suspension from day 0 to day 4. At day 8, spontaneous beating
was visible around the EBs. The beating cells continued to
increase till day 10. Compared with the control group, the
edge of EBs was not neat and smooth in the LYRM1 knock-
down group. In the subsequent study, we detected the expres-
sion of cardiomyogenesis-specific markers (GATA4 and
Nkx2-5) by real-time PCR,which shown that GATA4 and
Nkx2-5 expression was significantly down-regulated during
P19 cell differentiation into cardiomyocytes on days 6 and 10
in the LYRM1 knockdown group compared with the control
group at the same time points (Fig. 4b,c; *P<0.05,
**p < 0.01). Although the expression of cardiomyogenesis-
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specific markers detected by Western blots had no marked
difference during P19 cell differentiation into cardiomyocytes
on days 6, there was significantly down-regulated on days 10
in the LYRM1 knockdown group compared with the control
group. These results suggested that LYRM1 knockdown sup-
pressed DMSO-induced myocardial cell differentiation of P19
cells.
Effect of LYRM1 on mitochondrial DNA copy number
The mtDNA copy number per mitochondrion is regarded gen-
erally as constant in most mammalian cell types(Robin and
Wong 1988). Therefore, the mtDNA copy number is generally
considered as the relative quantity of mitochondria and re-
flects mitochondrial function. We used real-time PCR to de-
termine the mtDNA copy number in LYRM1 silenced and
control cells and the results showed that there was no marked
difference in mtDNA copy number between the two groups
(Fig. 5,P > 0.05).
Cellular ATP production was decreased upon LYRM1
knockdown
In cardiomyocytes, energy mainly originates from mitochon-
dria where ATP is generated. Impaired mitochondria may lead
to a lack of ATP. Here, we found that the cellular ATP pro-
duction decreased dramatically in the LYRM1 silenced cells
(Fig. 6, *** P < 0.001).
Effects of LYRM1 knockdown on intracellular ROS levels
and MMP
In this study, we measured ROS levels by fluorescence mi-
croscopy and flow cytometry following treatment of cells with
Fig. 1 Appraisal of LYRM1
suppression efficiency. LYRM1
mRNA relative to GAPDH in the
lentiviral-LYRM1-shRNA-
transfected P19 cells was
examined by real-time PCR in
comparison with lentiviral-NC-
shRNA-transfected P19 cells. The
mRNA inhibitory efficiency at
day 0 and 10 were 51 % and
58 %, respectively (*P < 0.05 vs.
negative control (NC) cells)
Fig. 2 LYRM1 gene silencing
reduces P19 cell proliferation.
P19 cells were transfected with
pGLV–LYRM1–shRNA
(LYRM1 RNAi) or pGLV–NC–
shRNA lentivirus (NC). Cell
growth was quantified using the
CCK-8 cell viability assay (a) and
cell cycle analysis (b). Values are
the mean ± SD of three
independent experiments
(n = 6,**P < 0.01)
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the fluorescent H2-DCFDA probe. As shown in Fig. 7, the
fluorescence signals in LYRM1-silenced cells were higher
than those of the control, indicating that silencing LYRM1
increased ROS generation (***P < 0.001). JC-1 is a
fluorescent probe that applied widely to assess the MMP. In
the mitochondrial matrix, JC-1 aggregates into a polymer to
generate a red fluorescence at the high level of MMP, while
JC-1 produces a green fluorescence without aggregating at the
Fig. 3 LYRM1 gene silencing
induces P19 cell apoptosis in
response to serum starvation. P19
cells were transfected with
pGLV–LYRM1– shRNA
(LYRM1 RNAi) or pGLV–NC–
shRNA lentivirus (NC), serum
starved for 24 h, and then cultured
in complete media for 24 h.
Apoptosis was quantified by flow
cytometry using Annexin V-APC/
7-AAD staining (a, b) and the
caspase-3 activity assay (c,d).
Values are the mean ± standard
deviation of three independent
experiments (n = 6,*P < 0.05)
Fig. 4 Effect of LYRM1 gene silencing on P19 cell differentiation. a P19
cell differentiation induced by 1 % DMSO. Micrographs show the
morphological characteristics at day (D) 0, 4, 6, and 10 (×20). b qRT-
PCR analysis of relative GATA4 and Nkx2.5 mRNA expression during
differentiation. There were remarkable differences in the expression
levels of these marker genes between the LYRM1 gene silencing and
negative control groups. Data are the mean ± SD of three
experiments(*P < 0.05,**p < 0.01). c Western blot detection of the
protein levels of the marker genes during differentiation
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low level of MMP. In this study, fluorescence microscopy and
flow cytometry were used to evaluate MMP reflected by the
relative proportion of red and green fluorescence. Both
methods showed that silencing LYRM1 produced a decrease
in the MMP (Fig.7, ** P < 0.01).
Discussion
The majority of scientists believed that CHD arises
through various combinations of genetic and environ-
mental contributors (Blue et al. 2012; Nora 1968).
Although many genes have been found in the
cardiogenesis process through animal studies, only a
few genes related to CHD in humans have been identi-
fied (Joziasse et al. 2008). To date, the precise molecu-
lar mechanisms of CHD are still unclear.
In our previous trials, multi-tissue expression analysis
of LYRM1 supported a role for LYRM1 in human heart
development (Qiu et al. 2009). In addition, we found
that LYRM1 promoted proliferation and inhibited apo-
ptosis in embryonic myocardial cells, which might have
the potential to modulate cell growth, apoptosis, and
heart development(Zhu et al. 2010). Therefore, we aim
to interpret the effect of LYRM1 on heart development
by silencing its expression using small interfering RNA
(siRNA).
CHD is strongly linked with the differentiation, pro-
liferation, and apoptosis of myocardial cells (Levy et al.
2007a; Levy et al. 2007b). Therefore, we investigated
the effects of LYRM1 knockdown on P19 cell differen-
tiation, proliferation, and apoptosis by construction of
the stable LYRM1 silenced cell line. As shown by the
m o r p h o l o g i c a l c h a n g e s a n d e x p r e s s i o n o f
cardiomyogenesis-specific molecular markers (GATA4
and Nkx2.5), we observed that knockdown of LYRM1
inhibi ted the different ia t ion of P19 cel ls into
cardiomyocytes. Furthermore, the CCK-8 assay showed
that P19 cells silencing LYRM1 grew slower than con-
trol cells, and cell cycle analysis indicated a remarkable
decrease in the percentage of cells entering the S-phase
and distinctly increased G1 phase fraction in LYRM1-
silenced P19 cells. Meanwhile, Flow cytometry and
measurement of caspase-3 activity revealed that apopto-
sis of P19 cells with silencing LYRM1 was significantly
upregulated. These data indicated that LYRM1 knock-
down dramatically inhibited proliferation, differentiation
and promoted apoptosis in P19 cells.
Embryonic fetal heart growth depends on the balance
between myocyte proliferation and apoptosis, and inad-
equate proliferation or excess apoptosis can directly or
indirectly result in CHD (Fiorina et al. 2004; Srivastava
2006). Therefore, we speculate that LYRM1 knockdown
may break the balance between proliferation and apo-
ptosis in P19 cells and then affect the differentiation
of cardiac precursors into mature cardiomyocytes.
However, the precise molecular mechanism that under-
lies this effect still remains unknown.
Apoptosis is the essential event of a vertebrate’s or-
gan formation and development process. Too much or
no degree of apoptosis can cause congenital heart de-
fects (Fiorina et al. 2004). Michael et al. suggested that
mitochondrial function influenced transmission and am-
plification of apoptosis signals (Crow et al. 2004). Cell
apoptosis, in turn, induced dynamic changes in the
function and structure of mitochondria (Martinou and
Youle 2011; Ugarte-Uribe and Garcia-Saez 2014).
Therefore, in the present study, we further explored
the effects of LYRM1 knockdown on mitochondrial
function in P19 cells.
Fig. 5 Effects of LYRM1 knockdown on the mitochondrial DNA copy
number in differentiated cells. P19 cells transfected with pGLV–
LYRM1– shRNA and the negative control(NC) cells were induced to
differentiate. On the 10th day of differentiation, cellular mtDNA
content was evaluated by real-time PCR analysis with primers designed
to the CytB and 28S rRNA genes (n = 6). The CytB to28S rRNA gene
ratio reflects the concentration of mitochondria per cell. P > 0.05 in
comparison with negative control (NC) cells
Fig. 6 Effects of LYRM1 knockdown on intracellular ATP production in
the differentiated cells. On the 10th day of differentiation, total cellular
ATP levels were measured and normalized to the protein concentration.
The results are representative of those values obtained from three
independent experiments (n = 6). ***P < 0.001 in comparison with
negative control (NC) cells
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We found that suppression of LYRM1 expression
caused mitochondria dysfunction. Firstly, LYRM1
knockdown significantly increased the ROS level.
Mitochondria are a major source of intracellular ROS,
and mitochondria become dysfunctional and ROS accu-
mulate as an intermediate with cel l apoptosis
increasing(Matsusaka and Ichikawa 1997). Then, the
high concentrations of ROS further lead to mitochondri-
al dysfunction (Choksi et al. 2004). Furthermore, we
observed that LYRM1 knockdown significantly de-
creased mitochondrial adenosine triphosphates (ATP)
content and Mitochondrial Membrane Potential (MMP).
It is well-known that the energy supply of cells is main-
ly generated from the mitochondrial ATP. We speculated
that the decline in ATP synthesis accompanied by the
impaired mitochondrial function would lead to an inad-
equate supply of cardiomyocyte energy, possibly induc-
ing stagnation of cardiogenesis. In addition, MMP, an
electrochemical gradient of protons between the inner
and outer membranes, is fundamental for the conversion
of ADP to ATP catalyzed by ATP synthase(Brown
1992), which can directly reflect mitochondrial function.
The decreased MMP could cause mitochondria to swell,
changing their permeability. Then, cytochrome c would
release into the cytoplasm with the opening of the per-
meability transition (PT) pore and activate some prote-
ase systems, resulting in apoptosis increased (Tanaka
et al. 2002). Therefore, we concluded that the increased
apoptosis in LYRM1-silencing cells was likely to be
associated with the increased ROS and the reduced
MMP.
In theory, the deterioration of mitochondrial function
would destroy the integrity of the mtDNA, resulting in
a reduction of the mtDNA copy number. However, the
difference in mtDNA copy number showed no statistical
significance in fact. We speculated that there might be
some other compensatory mechanisms that protected im-
paired mitochondria.
In conclusion, we demonstrated that LYRM1 knock-
down significantly inhibited proliferation and differenti-
ation and promoted apoptosis in P19 cells. In addition,
LYRM1 knockdown induced mitochondrial impairment
in P19 cells during differentiation, which was reflected
in decreased MMP, cellular ATP production and in-
creased ROS levels. These findings may provide a
new viewpoint into the mechanisms of cardiac abnor-
malities. Furthermore, LYRM1 may be a potential new
therapeutic target for CHDs. Therefore, the next step in
this study would be to confirm whether abnormalities in
LYRM1 knockdown contribute to CHD in vivo.
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Fig. 7 Effects of LYRM1 knockdown on intracellular reactive oxygen
species (ROS) content and mitochondrial membrane potential (MMP) in
the differentiated cells. (A)On the 10th day of differentiation, ROS levels
were detected using a fluorescence microscopy (exCitation at 488 nm,
emission at 530 nm) and fluorescence activated cell sorting (FACS)
analysis. (n = 6, ***P < 0.001 vs. negative control (NC) cells). (B)On
the 10th day of differentiation, MMP was detected by a fluorescence
microscopy and FACS. (n = 6, **P < 0.01 vs. the NC cells)
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